|
|
 | | | |
- close
- close
- close
- close
This excerpt taken from the AXTI 10-Q filed May 11, 2009. Research and Development
Research and development expenses decreased $44,000, or 8.7% to $460,000 for the three months ended March 31, 2009 from $504,000 for the three months ended March 31, 2008. The decrease was primarily due to the absence of bonus accruals beginning in 2009, discontinuation of our payment of expatriate per diem for US-based employees working substantially in China, and less outside consulting costs.
These excerpts taken from the AXTI 10-K filed Mar 31, 2009. Research and Development To maintain and improve our competitive position, we focus our research and development efforts on designing new proprietary processes and products, improving the performance of existing products and reducing manufacturing costs. We have assembled a multi-disciplinary team of skilled scientists, engineers and technicians to meet our research and development objectives. Our current substrate research and development activities focus on continued development and enhancement of GaAs, InP and Ge substrates, including haze reduction, improved yield, enhanced surface and electrical characteristics and uniformity, greater substrate strength and increased crystal length. During 2008, we continued to spend some research and development resources to reduce surface quality problems we experienced with our GaAs and InP substrates for some customers, particularly related to surface morphology. We continue to work on issues related to surface quality, and expect that research and development in this area will continue in 2009. Research and development expenses were $2.2 million in 2008, compared with $1.7 million in 2007 and $2.4 million in 2006. Given the current economic climate, we expect our rate of expenditure on research and development costs in 2009 to remain flat while exploring other methods to grow our crystals and improve on haze reduction. Research and development at our joint ventures has been minimal. Research and Development To maintain and improve our competitive position, we focus our research and development efforts on designing new proprietary processes Our Research Research and Development Research and development costs consist primarily of salaries including stock compensation expense and related personnel costs, depreciation and product testing and are expensed as incurred. Research and Development Research and development costs consist primarily of salaries including stock compensation expense and related personnel costs, This excerpt taken from the AXTI 10-Q filed May 12, 2008. Research and Development
Research and development expenses increased $ 44,000, or 9.6% to $ 504,000 for the three months ended March 31, 2008 from $460,000 for the three months ended March 31, 2007. The increase was due to increases in salary and related costs as a result of the appointment of a new chief technology officer effective December 31, 2007, and general annual salary and related cost increases partially offset by lower new products testing costs.
22
These excerpts taken from the AXTI 10-K filed Mar 14, 2008. Research and Development Research and development costs consisting primarily of salaries including stock compensation expense and related personnel costs, depreciation and product testing are expensed as incurred. Research and Development Research and development costs consisting primarily of salaries including stock compensation expense and related personnel costs, depreciation and product testing This excerpt taken from the AXTI 10-Q filed May 11, 2007. Research and Development
Research and development expenses decreased $0.1 million, or 13.9% to $0.5 million for the three months ended March 31, 2007 from $0.5 million for the three months ended March 31, 2006, from savings in salary and related costs as a result of the retirement of Dr. Morris Young, our former Chief Technology Officer effective December 31, 2006. 22 This excerpt taken from the AXTI 10-K filed Mar 23, 2007. Research and Development Research and development costs consisting primarily of salaries including stock compensation expense and related personnel costs, depreciation and product testing are expensed as incurred. This excerpt taken from the AXTI 10-Q filed May 12, 2006. Research and Development
Research and development expenses increased $172,000, or 47.5%, to $534,000 for the three month period ended March 31, 2006 compared with $362,000 for the three month period ended March 31, 2005, as a result of our appointing Dr. Morris Young as our Chief Technology Officer to enhance our technology leadership, thereby causing the related compensation costs to be included in research and development expense rather than general and administrative expense, and for stock based compensation costs. We believe that continued investment in product development is critical to attaining our strategic objectives of maintaining and enhancing our technology leadership.
This excerpt taken from the AXTI 10-K filed Mar 30, 2006. Research and Development
To maintain and improve our competitive position, we focus our research and development efforts on designing new proprietary processes and products, improving the performance of existing products and reducing manufacturing costs. We have assembled a multi-disciplinary team of skilled scientists, engineers and technicians to meet our research and development objectives. Our current substrate research and development activities focus on continued development and enhancement of GaAs, InP and Ge substrates, including haze reduction, improved yield, enhanced surface and electrical characteristics and uniformity, greater substrate strength and increased crystal length. During 2005, we continued to spend some research and development resources to reduce surface quality problems we experienced with our GaAs and InP substrates for some customers, particularly related to surface morphology. We continue to work on issues related to surface quality. Research and development expenses were $1.7 million in 2005, compared with $1.5 million in 2004 and $1.3 million in 2003. We expect to maintain our rate of expenditure on research and development costs in 2006. 9 Research and development at our joint ventures will remain at a minimal level. This excerpt taken from the AXTI 10-Q filed May 9, 2005. Research and Development
Research and development expenses increased $21,000, or 6%, to $362,000 for the three month period ended March 31, 2005 compared with $341,000 for the three month period ended March 31, 2004. We believe that continued investment in product development is critical to attaining our strategic objectives of maintaining and increasing our technology leadership, and as a result, we expect research and development expenses to remain at the levels of recent quarters or increase in future periods. Research and development efforts during 2005 were focused primarily on improving the yield and surface quality of our GaAs substrates.
This excerpt taken from the AXTI 10-K filed Mar 18, 2005. Research and Development To maintain and improve our competitive position, we focus our research and development efforts on designing new proprietary processes and products, improving the performance of existing products and reducing manufacturing costs. We have assembled a multi-disciplinary team of skilled scientists, engineers and technicians to meet our research and development objectives. Our current substrate research and development activities focus on continued development and enhancement of GaAs, InP and Ge substrates, including haze reduction, improved yield, enhanced surface and electrical characteristics and uniformity, greater substrate strength and increased crystal length. In addition, during 2004 we spent some research and development resources to reduce surface quality problems we experienced with our GaAs and InP substrates for some customers, particularly related to surface morphology. We continue to work on issues related to surface quality. Research and development expenses were $1.5 million in 2004, compared with $1.3 million in 2003 and with $2.3 million in 2002. We expect to increase our rate of expenditure on research and development costs by approximately 15% in 2005. | EXCERPTS ON THIS PAGE:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||
